Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al
The specific impacts to any one plan or organization boils down to whether they cover GLP-1s for weight loss purposes
Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss
Triple Receptor Co-Agonism Insulin secretion stimulation, appetite suppression, and gastric emptying delay
Last reviewed: June 1, 2026 Last updated: June 1, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Like GLP-1, GIP stimulates insulin secretion from pancreatic cells in a glucose-dependent manner (124)